WhichPeps

GHK-Cu + BPC-157 + TB-500 blend

Multi-peptide blend

Skintissue-repair
Generic peptide vial illustrationGHK-Cu + BPC-157 + TB-500 blend
Evidence levelMixed evidence
Human evidenceSee evidence
Regulatory statusNo approved medicine identified

What you need to know in 20 seconds

What is it?Multi-peptide blend
Research focusSkin/tissue-repair/recovery claims
Human evidenceNo direct controlled human trial of the GHK-Cu + BPC-157 + TB-500 three-component blend was identified; evidence must be assessed component by component.
Regulatory statusNo approved medicine corresponding to this blend was identified.
Main limitationsHuman efficacy, synergy, safety, route, ratio or dosing for the three-way blend.
SafetyUnknown blend interactions and purity; component-specific safety limitations remain.
i
No direct controlled human trial of the GHK-Cu + BPC-157 + TB-500 three-component blend was identified; evidence must be assessed component by component.

What the evidence actually supports

  • ✓Evidence varies by endpoint. See the study records below.

What is not established / key limitations

  • ×Human efficacy, synergy, safety, route, ratio or dosing for the three-way blend.

Selected study & evidence records

No structured study detail is currently rendered for this page.

Safety and unknowns

Unknown blend interactions and purity; component-specific safety limitations remain.

Unknown blend interactions and purity; component-specific safety limitations remain.

Technical details

Mechanism / biologyA multi-compound blend combining GHK-Cu, BPC-157 and TB-500 is marketed in some research markets. There is no validated combined clinical mechanism or interaction profile; evidence must be assessed component by component.
Route / formulation boundaryBlend composition, ratio, route and manufacturing quality vary between products. Component literature does not establish the efficacy or safety of the mixture.
Identity / data-quality noteThe BPC-157 + TB-500 rat combination study does not validate the addition of GHK-Cu.
Dosing evidence statusDosing research conclusion recorded. No clinical regimen for the GHK-Cu + BPC-157 + TB-500 blend identified; individual-component evidence cannot establish a combined dose.
Identifiers & alternate namesGLOW · GLOW Stack · GLOW peptide

Evidence rule: WhichPeps keeps human, animal, laboratory, regulatory and product/formulation evidence distinct. Common names help people find the page; they do not change the underlying scientific identity.